Michael J. Shamblott

4.5k total citations · 1 hit paper
50 papers, 3.4k citations indexed

About

Michael J. Shamblott is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Michael J. Shamblott has authored 50 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Surgery and 13 papers in Genetics. Recurrent topics in Michael J. Shamblott's work include Pluripotent Stem Cells Research (17 papers), Pancreatic function and diabetes (8 papers) and Glycosylation and Glycoproteins Research (7 papers). Michael J. Shamblott is often cited by papers focused on Pluripotent Stem Cells Research (17 papers), Pancreatic function and diabetes (8 papers) and Glycosylation and Glycoproteins Research (7 papers). Michael J. Shamblott collaborates with scholars based in United States, Japan and Finland. Michael J. Shamblott's co-authors include John D. Gearhart, Gary W. Litman, Joyce Axelman, George R. Huggins, Paul D. Blumenthal, John W. Littlefield, Shunping Wang, Peter J. Donovan, Ronda T. Litman and K. Hinds and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Michael J. Shamblott

50 papers receiving 3.2k citations

Hit Papers

Derivation of pluripotent stem cells from cultured human ... 1998 2026 2007 2016 1998 250 500 750 1000

Peers

Michael J. Shamblott
Glenn L. Radice United States
Justin C. Grindley United States
Catherine E. Ovitt United States
Daniel B. Constam Switzerland
Junhao Mao United States
Michael J. Shamblott
Citations per year, relative to Michael J. Shamblott Michael J. Shamblott (= 1×) peers Corrinne G. Lobe

Countries citing papers authored by Michael J. Shamblott

Since Specialization
Citations

This map shows the geographic impact of Michael J. Shamblott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Shamblott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Shamblott more than expected).

Fields of papers citing papers by Michael J. Shamblott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Shamblott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Shamblott. The network helps show where Michael J. Shamblott may publish in the future.

Co-authorship network of co-authors of Michael J. Shamblott

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Shamblott. A scholar is included among the top collaborators of Michael J. Shamblott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Shamblott. Michael J. Shamblott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markowitz, Joseph, Michael J. Shamblott, Andrew S. Brohl, et al.. (2024). First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular Cancer Therapeutics. 23(8). 1139–1143. 5 indexed citations
2.
Shamblott, Michael J., et al.. (2016). Neurogenin 3 is regulated by neurotrophic tyrosine kinase receptor type 2 (TRKB) signaling in the adult human exocrine pancreas. Cell Communication and Signaling. 14(1). 23–23. 7 indexed citations
3.
O’Driscoll, Marci, et al.. (2015). Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate. PLoS ONE. 10(8). e0133862–e0133862. 42 indexed citations
4.
Shamblott, Michael J., Devin S. Gary, Visar Belegu, et al.. (2013). Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ. Experimental Neurology. 247. 113–121. 113 indexed citations
5.
Thompson, Susan A., Paul W. Burridge, Elizabeth A. Lipke, et al.. (2012). Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. Journal of Molecular and Cellular Cardiology. 53(1). 15–23. 28 indexed citations
6.
Barnett, Brad P., Jesús Ruı́z-Cabello, Partha Hota, et al.. (2011). Use of perfluorocarbon nanoparticles for non‐invasive multimodal cell tracking of human pancreatic islets. Contrast Media & Molecular Imaging. 6(4). 251–259. 68 indexed citations
7.
Crane, Janet L., Michael J. Shamblott, Joyce Axelman, et al.. (2009). Imprinting Status of GαS, NESP55, and XLαs in Cell Cultures Derived from Human Embryonic Germ Cells: GNAS Imprinting in Human Embryonic Germ Cells. Clinical and Translational Science. 2(5). 355–360. 10 indexed citations
8.
Locke, Jayme E., Michael J. Shamblott, & Andrew M. Cameron. (2009). Stem Cells and the Liver: Clinical Applications in Transplantation. Advances in Surgery. 43(1). 35–51. 7 indexed citations
9.
Zhan, Xiangcan, Christine Hill, Cory Brayton, & Michael J. Shamblott. (2008). Cells Derived from Human Umbilical Cord Blood Support the Long-Term Growth of Undifferentiated Human Embryonic Stem Cells. Cloning and Stem Cells. 10(4). 513–522. 9 indexed citations
10.
Hillel, Alexander T., et al.. (2008). Embryonic Germ Cells Are Capable of Adipogenic Differentiation In Vitro and In Vivo. Tissue Engineering Part A. 15(3). 479–486. 16 indexed citations
11.
Locke, Jayme E., Zhaoli Sun, Daniel Warren, et al.. (2008). Generation of Humanized Animal Livers Using Embryoid Body-derived Stem Cell Transplant. Annals of Surgery. 248(3). 487–493. 9 indexed citations
12.
Clark, Gregory O., et al.. (2007). Glucose responsive insulin production from human embryonic germ (EG) cell derivatives. Biochemical and Biophysical Research Communications. 356(3). 587–593. 7 indexed citations
13.
Jansen, Jacobus F.A., Michael J. Shamblott, Peter C.M. van Zijl, et al.. (2006). Stem cell profiling by nuclear magnetic resonance spectroscopy. Magnetic Resonance in Medicine. 56(3). 666–670. 33 indexed citations
14.
Kerr, Candace L., Michael J. Shamblott, & John D. Gearhart. (2006). Pluripotent Stem Cells from Germ Cells. Methods in enzymology on CD-ROM/Methods in enzymology. 419. 400–426. 26 indexed citations
15.
Shamblott, Michael J., et al.. (2005). Transplanted human embryonic germ cell‐derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage. Journal of Neuroscience Research. 82(5). 592–608. 46 indexed citations
16.
Frimberger, Dominic, et al.. (2005). Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology. 65(4). 827–832. 46 indexed citations
17.
Phelps, John Y., et al.. (2003). Prolactin gene expression in human ovarian follicular cells. Fertility and Sterility. 79(1). 182–185. 18 indexed citations
18.
Shamblott, Michael J., et al.. (2002). Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene. Developmental Dynamics. 224(4). 373–380. 48 indexed citations
19.
Litman, Gary W., Chris T. Amemiya, Fiona Harding, et al.. (1991). Evolutionary Development of Immunoglobulin Gene Diversity. Advances in experimental medicine and biology. 292. 11–17. 3 indexed citations
20.
Haire, Robert N., Michael J. Shamblott, Chris T. Amemiya, & G. W. Litman. (1989). A secondXenopusimmunoglobulin heavy chain constant region isotype gene. Nucleic Acids Research. 17(4). 1776–1776. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026